Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients.

Wang, Cong; Chen, Fang; Liu, Yichen; Xu, Qingqing; Guo, Liang; Zhang, Xiaoqing; Ruan, Yunfeng; Shi, Ye; Shen, Lu; Li, Mo; Du, Huihui; Sun, Xiaofang; Ma, Jingsong; He, Lin; Qin, Shengying

Wang, Cong; Chen, Fang; Liu, Yichen; Xu, Qingqing; Guo, Liang; Zhang, Xiaoqing; Ruan, Yunfeng; Shi, Ye; Shen, Lu; Li, Mo; Du, Huihui; Sun, Xiaofang; Ma, Jingsong; He, Lin; Qin, Shengying.

Afiliação

Wang C; Life Science College, Anhui Medical University, Hefei, China.
Chen F; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Liu Y; Life Science College, Anhui Medical University, Hefei, China.
Xu Q; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Guo L; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Zhang X; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Ruan Y; The Fourth Hospital of Jinan City, Taishan Medical College, Jinan, China.
Shi Y; Department of Pharmacy, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Shen L; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Li M; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Du H; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Sun X; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Ma J; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
He L; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Qin S; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.

Front Pharmacol ; 9: 360, 2018.

Article em En | MEDLINE | ID: mdl-29695969

Palavras-chave

adverse drug responses; erlotinib; non-small cell lung cancer; single-nucleotide polymorphism (SNP); therapeutic responses

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google